Delayed neuroprotection against cerebral ischemia reperfusion injury: putative role of BDNF and GSK-3β

References

• Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007;87:179–97
   PubMed Web of Science ®Google Scholar
• Hung LM, Huang JP, Liao JM, et al. Insulin renders diabetic rats resistant to acute ischemic stroke by arresting nitric oxide reaction with superoxide to form peroxynitrite. J Biomed Sci 2014;21:92
   PubMed Web of Science ®Google Scholar
• Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Interv Neurol 2012;1:185–99
   Google Scholar
• Hattori K, Lee H, Hurn PD, et al. Cognitive deficits after focal cerebral ischemia in mice. Stroke 2000;31:1939–44
   PubMed Web of Science ®Google Scholar
• Ye R, Yang Q, Kong X, et al. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit Care Med 2012;40:2685–93
   PubMed Web of Science ®Google Scholar
• Wei H, Yao X, Yang L, et al. Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. Mol Neurobiol 2014;49:326–36
   PubMed Web of Science ®Google Scholar
• Wang, ZF, Fessler EB, Chuang DM. Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models. Acta Pharmacol Sin 2011;32:1433–45
   PubMed Web of Science ®Google Scholar
• Wang Z, Leng Y, Tsai LK, et al. Valproic acid attenuates blood–brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 2011;31:52–7
   PubMed Web of Science ®Google Scholar
• Chuang DM, Wang Z, Chiu CT. GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 2011;4:15
   PubMed Web of Science ®Google Scholar
• Leng Y, Liang MH, Ren M, et al. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008;28:2576–88
   PubMed Web of Science ®Google Scholar
• Croce N, Mathe AA, Gelfo F, et al. Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration. J Psychopharmacol 2014;28:964–72
   PubMed Web of Science ®Google Scholar
• Li H, Li Q, Du X, et al. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 2011;31:2106–15
   PubMed Web of Science ®Google Scholar
• Zhu ZF, Wang QG, Han BJ, Willaim CP. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res Bull 2010;83:272–7
   PubMed Web of Science ®Google Scholar
• Takahashi T, Steinberg GK, Zhao H. Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis 2012;3:226
   PubMed Web of Science ®Google Scholar
• Xie C, Zhou K, Wang X, et al. Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia. PLoS One 2014;9:e107192
   PubMed Web of Science ®Google Scholar
• Sharma S, Taliyan R. Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice. Biochem Biophy Res Commun 2014;452:1009–15
   PubMed Web of Science ®Google Scholar
• Sharma S, Taliyan R. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 2014;388:337–49
   Google Scholar
• Pateliya BB, Singh N, Jaggi AS. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull 2008;31:1755–60
   PubMed Web of Science ®Google Scholar
• Sharma S, Taliyan R, Ramagiri S. Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. J Mol Neurosci 2014;56:1–11
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75
   PubMed Web of Science ®Google Scholar
• Ellmann GL, Courtney KD, Andres V, Feather stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95
   PubMed Web of Science ®Google Scholar
• Wills E. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966;99:667–76
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 1982;126:131–8
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7
   PubMed Web of Science ®Google Scholar
• Pizzorusso T, Ratto GM, Putignano E, Maffei L. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci 2000;20:2809–16
   PubMed Web of Science ®Google Scholar
• Platenik J, Fisar Z, Buchal R, et al. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer’s disease and depression. Prog Neuropsychopharmacol Biol Psychiatry 2014;50:83–93
   PubMed Web of Science ®Google Scholar
• Won J, Lee S, Park S, Hong Y. Protective effects of melatonin against ischemic neuronal damage in rats with transient focal cerebral ischemia. FASEB J 2015;29:186–92
   Google Scholar
• Li WL, Cai HH, Wang B, et al. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 2009;87:112–22
   PubMed Web of Science ®Google Scholar
• Xu J, Culman J, Blume A, et al. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003;34:1287–92
   PubMed Web of Science ®Google Scholar
• Seo HG, Kim DY, Park HW, et al. Early motor balance and coordination training increased synaptophysin in subcortical regions of the ischemic rat brain. J Korean Med Sci 2010;25:1638–45
   PubMed Web of Science ®Google Scholar
• Ben Assayag E, Shenhar-Tsarfaty S, Ofek K, et al. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med 2010;16:278
   PubMed Web of Science ®Google Scholar
• Eldar-Finkelman H, Martinez A. GSK-3 inhibitors: preclinical and clinical focus on CNS. Front Mol Neurosci 2011;4:32
   PubMed Web of Science ®Google Scholar
• King MK, Pardo M, Cheng Y, Downey K, Jope RS, Beurel E, et al. Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments. Pharmacol Ther 2014;141:1–12
   PubMed Web of Science ®Google Scholar
• Ahmed T, Gilani AH. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol Biochem Behav 2009;91:554–9
   PubMed Web of Science ®Google Scholar
• Saez-Valer J, Gonzalez-Garci A. Acetylcholinesterase activity and molecular isoform distribution are altered after focal cerebral ischemia. Mol Brain Res 2003;117:240–4
   PubMedGoogle Scholar
• Sinha, K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002;71:655–65
   PubMed Web of Science ®Google Scholar
• Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000;17:871–90
   PubMed Web of Science ®Google Scholar
• Collino M, Thiemermann C, Mastrocola R, et al. Treatment with the glycogen synthase kinase-3β inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 2008;30:299–307
   PubMed Web of Science ®Google Scholar
• McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008;5:45
   PubMed Web of Science ®Google Scholar
• Zaremba J, Losy J. Early TNF-α levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001;104:288–95
   PubMed Web of Science ®Google Scholar
• Maixner DW, Weng HR. The role of glycogen synthase kinase 3 beta in neuroinflammation and pain. J Pharmaceu Pharmacol 2013;1:001
   Google Scholar
• Woo NH, Lu B. Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006;12:43–56
   PubMed Web of Science ®Google Scholar
• Endo H, Nito C, Kamada H, et al. Activation of the Akt/GSK3β signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 2006;26:1479–89
   PubMed Web of Science ®Google Scholar
• Zhao H, Shimohata T, Wang JQ, et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neuroscience 2005;25:9794–806
   PubMed Web of Science ®Google Scholar
• Sasaki C, Hayashi T, Zhang WR, et al. Different expression of glycogen synthase kinase-3 β between young and old rat brains after transient middle cerebral artery occlusion. Neurol Res 2001;23:588–92
   PubMed Web of Science ®Google Scholar